Skip to main content
. 2026 Jun 12;15(12):1072. doi: 10.3390/cells15121072
NB Neuroblastoma
TIME Tumor Immune Evasion
HR-NB High-risk Neuroblastoma
NCC Neural Crest Cells
TME Tumor Microenvironment
TAMs Tumor-associated Macrophages
MDSCs Myeloid-Derived Suppressor Cells
Tc T Lymphoid cells
DC Dendritic Cells
NK Natural Killer Cells
TDE Tumor-Derived Exosomes
CT Chemotherapy
RT Radiotherapy
ASCT Autologous Stem Cell Rescue
IMT Incorporation of Immunotherapy
OS Overall Survival
MRD Minimal Residual Disease
MHC Major Histocompatibility Complex
CSC Cancer Stem Cell
scRNA-seq Single Cell RNA Sequence
NO Nitric Oxide
TCR T Lymphoid cells Receptor
HIF Hypoxia-Inducible Factor
CTL Cytotoxic T Lymphocyte
APM Antigen Processing Machinery
eAdo Extracellular Adenosine
A2AR A2A Adenosine Receptor
APCs Antigen-Presenting Cells
Treg T-regulatory cell
FAO Fatty Acid Oxidation
OXPHOS Oxidative Phosphorylation
GPX4 Glutathione Peroxidase 4
HDAC Histone Deacetylase
HDACi HDAC inhibitors
DNMT DNA Methyltransferase
DNMTi DNMT inhibitors
BET Bromodomain and extraterminal domain
BETi BET inhibitors
LSD1 Lysine specific demethylase 1
LSD1i LSD1 inhibitors
PRC1 Polycomb Repressive Complex 1
HAT Histone Acetyltransferase
PROTACs Proteolysis-Targeting Chimeras
EVs Extracellular Vehicles
MVB Endosomal-Multivesicular Body
IL-2 Interleukin-2
PGE2 Prostaglandin E2
ARG1 Arginase-1
iNOS Inducible Nitric Oxide Synthase
CSC-Exos CSC-derived Exosomes
ADCC Antibody-Dependent Cellular Cytotoxicity
CAR Chimeric Antigen Receptor
NK-Exos NK-cell-derived Exosomes
BsAbs Bispecific Antibodies
Ovs Oncolytic Viruses